Pharmacological treatments have been widely investigated in pre-clinical animal trials to evaluate their usefulness in reducing cognitive, behavioural and motor problems after traumatic brain injury (TBI). However, the relative efficacy of these agents has yet to be evaluated, making it difficult to assess the strength of evidence for their use in a clinical population. A meta-analytic review of research (1980–2009) was therefore conducted to examine the impact of pharmacological treatments administered to adult male rodents after experimental TBI on cognitive, behavioural, and motor outcome. The PubMed and PsycInfo databases were searched using 35 terms. Weighted Cohen’s d effect sizes, percent overlap, Fail-Safe N statistics and confidence intervals were calculated for each treatment. In total, 91 treatments were evaluated in 223 pre-clinical trials, comprising 5988 rodents. Treatments that were investigated by multiple studies and showed large and significant treatment effects were of greatest interest. Of the 16 treatments that were efficacious, six improved cognition, 10 improved motor function and no treatment improved behaviour (depression/anxiety, aggression, zoosocial behaviour). Treatment benefits were found across a range of TBI models. Drug dosage and treatment interval impacted on treatment effects.
ArlinghausKAShoaibAMPriceTR (2005) Neuropsychiatric assessment. In: SilverJMMcAllisterTWYudofskySC (eds) Textbook of Traumatic Brain Injury. Washington, DC: American Psychiatric Publishing Inc.
2.
AshleyMJ (2004) Traumatic Brain Injury: Rehabilitative Treatment and Case Management. Boca Raton: CRC Press.
3.
BarbreABHoaneMR (2006) Magnesium and riboflavin combination therapy following cortical contusion injury in the rat. Brain Res Bull69: 639–646.
4.
BareyreFMSaatmanKEHelfaerMASinsonGWeisserJDBrownAL. (1999) Alterations in ionized and total blood magnesium after experimental traumatic brain injury: Relationship to neurobehavioural outcome and neuroprotective efficacy of magnesium chloride. J Neurochem73: 271–280.
5.
BaroneFCOhlsteinEHHunterAJCampbellCAHadinghamSHParsonsAA. (2000) Selective antagonism of endothelin-A-receptors improves outcome in both head trauma and focal stroke in rat. J Cardiovasc Pharmacol36(5 Suppl 1): S357–S361.
6.
BelayevLAlonsoOHuhPWZhaoWBustoRGinsbergMD (1999) Posttreatment with high-dose albumin reduces histopathological damage and improves neurological deficit following fluid percussion brain injury in rats. J Neurotrauma16(6): 445–453.
7.
BermanRFVerweijBHMuizelaarJP (2000) Neurobehavioral protection by the neuronal calcium channel blocker ziconotide in a model of traumatic diffuse brain injury in rats. J Neurosurg93: 821–828.
8.
BessonVCChenXRPlotkineMMarchand-VerrecchiaC (2005) Fenofibrate, a peroxisome proliferator-activated receptor a antagonist, exerts neuroprotective effects in traumatic brain injury. Neurosci Lett388: 7–12.
9.
BrauzeDJanuchowskiRSzyfterK (2002) Differences between rats and mice in induction of 4S β-naphthoflavone-binding protein expression by treatment with β-naphthoflavone. J Appl Genet43(3): 371–376.
10.
BrowneKDLeoniMJIwataAChenX-HSmithDH (2004) Acute treatment with MgSO4 attenuates long-term hippocampal tissue loss after brain trauma in the rat. J Neurosci Res77: 878–883.
11.
ChenYShohamiEBassRWeinstockM (1998a) Cerebro-protective effects of ENA713, a novel acetylcholinesterase inhibitor, in closed head injury in the rat. Brain Res784: 18–24.
12.
ChenYShohamiEConstantiniSWeinstockM (1998b) Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse. J Neurotrauma15(4): 231–237.
13.
ChengJPAslamHAHoffmanANZafonteRDKlineAE (2007) The neurobehavioural benefit conferred by a single systemic administration of 8-OH-DPAT after brain trauma is confined to a narrow therapeutic window. Neurosci Lett416: 165–168.
14.
ClarkRSBVagniVANathanielPDJenkinsLWDixonCESzaboC (2007) Local administration of the poly(ADP-ribose) polymerase inhibitor INO-1001 prevents NAD+ depletion and improves water maze performance after traumatic brain injury in mice. J Neurotrauma24(8): 1399–1405.
15.
CohenJ (1977) Statistical Power Analysis for the Behavioural Sciences. New York: Academic Press.
16.
CohenJ (1992) Quantitative methods in psychology: A power primer. Psychol Bull112(1): 155–159.
17.
CooperJRBloomFERothRH (2003) The Biochemical Basis of Neuropharmacology. Oxford: Oxford University Press.
18.
De la TorreJC (1995) Treatment of head injury in mice, using a fructose 1,6-diphosphate and dimethyl sulfoxide combination. Neurosurgery37(2): 273–279.
19.
DempseyRJRaoVL (2003) Cytidinediphosphocholine treatment to decrease traumatic brain injury – induced hippocampal neuronal death, cortical contusion volume, and neurological dysfunction in rats. J Neurosurg98: 867–873.
20.
DixonCEFlinnPBaoJVenyaRHayesRL (1997a) Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats. Exp Neurol146: 479–490.
21.
DixonCEXiechengMAMarionDW (1997b) Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetlycholine release. J Neurotrauma14(3): 161–169.
22.
FadenAI (1993) Comparison of single and combination drug treatment strategies in experimental brain trauma. J Neurotrauma10(2): 91–100.
23.
FadenAIDemediukPPanterSSVinkR (1989) The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science244(4906): 798–800.
24.
FadenAIFoxGBFanLAraldiGLQiaoSWangS. (1999) Novel TRH analog improves motor and cognitive recovery after traumatic brain injury in rodents. Am J Physiol Regul Integr Comp Physiol277: 1196–1204.
25.
FadenAIKnoblachSMCernakIFanLVinkRAraldiGL. (2003) Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro and in vivo. J Cereb Blood Flow Metab23: 342–354.
26.
FengDFZhuZALuY-C (2004) Effects of magnesium sulfate on traumatic brain edema in rats. Chin J Traumatol7(3): 148–152.
27.
FinnieJW (2001) Animal models of traumatic brain injury: A review. Aust Vet J79(9): 628–633.
28.
FinnieJWBlumbergsPC (2002) Animal models: Traumatic brain injury. Vet Pathol39: 679–689.
29.
FrommLHeathDLVinkRNimmoAJ (2004) Magnesium attenuates post-traumatic depression/anxiety following diffuse traumatic brain injury in rats. J Am Coll Nutr23(5): 529S–533S.
30.
HammRJO‘DellDMPikeBRLyethBG (1993) Cognitive impairment following traumatic brain injury: The effect of pre- and post-injury administration of scopolamine and MK-801. Cogn Brain Res1: 223–226.
31.
HammRJTempleMDPikeBREllisEF (1996) The effect of postinjury administration of polyethylene glycol-conjugated superoxide dismutase (pegorgotein, dismutec) or lidocaine on behavioral function following fluid-percussion brain injury in rats. J Neurotrauma13(6): 325–332.
HeathDLVinkR (1998b) Neuroprotective effects of MgSO4 and MgCl2 in closed head injury: A comparative phosphorus NMR study. J Neurotrauma15(3): 183–189.
34.
HeathDLVinkR (1999) Improved motor outcome in response to magnesium therapy received up to 24 hours after traumatic diffuse axonal brain injury in rats. J Neurosurg90: 504–509.
35.
HedgesLVOlkinI (1985) Statistical Methods for Meta-analysis. Orlando: Academic Press Inc.
36.
HinsonJLambertDCLeVereTE (1996) Recovery of function after brain damage: Differential effects of blocking calcium uptake during the recovery of a learned behavior and the performance of the recovered behavior following neocortical brain injury. Brain Res Bull39(5): 311–316.
37.
HoaneMR (2005) Treatment with magnesium improves reference memory but not working memory while reducing GFAP expression following traumatic brain injury. Restor Neurol Neurosci23(2): 67–77.
38.
HoaneMRAkstulewiczSLToppenJ (2003a) Treatment with vitamin B3 improves functional recovery and reduces GFAP expression following traumatic brain injury in rats. J Neurotrauma20(11): 1189–1199.
39.
HoaneMRKnottsAAAkstulewiczSLAquilanoMMeansLW (2003b) The behavioral effects of magnesium therapy on recovery of function following bilateral anterior medial cortex lesions in the rat. Brain Res Bull60: 105–114.
40.
HoaneMRTanAAPierceJLAndersonGDSmithDC (2006) Nicotinamide treatment reduces behavioral impairments and provides cortical protection after fluid percussion injury in the rat. J Neurotrauma23(10): 1535–1548.
41.
HoaneMRWolyniakJGAkstulewiczSL (2005) Administration of riboflavin improves behavioral outcome and reduces edema formation and flial fibrillary acidic protein expression after traumatic brain injury. J Neurotrauma22(10): 1112–1122.
42.
HoffmanANChengJPZafonteRDKlineAE (2008) Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficits. Life Sci83: 602–607.
43.
HuangWChenYShohamiEWeinstockM (1999) Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse. Eur J Pharmacol366(2–3): 127–135.
44.
HunterJESchmidtFL (2004) Methods of Meta-Analysis: Correcting Error and Bias in Research Findings (2nd edn). Thousand Oaks: Sage Publications Inc.
45.
HunterJESchmidtFLJacksonGB (1982) Meta-analysis: Cumulating research findings across studies. (Vol. 4). Beverly Hills: Sage Publications Inc.
46.
JiBKopinASLogsdonCD (2000) Species differences between rat and mouse CCKA receptors determine the divergent acinar cell response to the cholecystokinin analog JMV-180*. J Biol Chem275(25): 19115–19120.
47.
JiYCKimYBParkSWHwangSNMinBKHongHJ. (2005) Neuroprotective effect of ginseng total saponins in experimental traumatic brain injury. J Korean Med Sci20: 291–296.
48.
KlineAEMassucciJLMaXZafonteRDDixonCE (2004) Bromocriptine reduces lipid peroxidation and enhances spatial learning and hippocampal neuron survival in a rodent model of focal brain trauma. J Neurotrauma21(12): 1712–1722.
49.
KlineAEWagnerAKWestergomBPMalenaRRZafonteRDOlsenAS. (2007) Acute treatment with the 5-HT1A receptor agonist 8-OH-DPAT and chronic environmental enrichment confer neurobehavioural benefit after experimental brain trauma. Behav Brain Res177: 186–194.
50.
KlineAEYuJHorvathEMarionDWDixonCE (2001) The selective 5-HT1A receptor agonist repinotan HCL attenuates histopathology and spatial learning deficits following traumatic brain injury in rats. Neuroscience106(3): 547–555.
51.
KlineAEYuJMassucciJLZafonteRDDixonCE (2002) Protective effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin against traumatic brain injury-induced cognitive deficits and neuropathology in adult male rats. Neurosci Lett333: 179–182.
52.
KnoblachSMFadenAI (2002) Administration of either anti-intercellular adhesion molecule-1 or a nonspecific control antibody improves recovery after traumatic brain injury in the rat. J Neurotrauma19(9): 1039–1050.
53.
KnollerNLeviLShoshanIReichenthalERazonNRappaportZH. (2002) Dexanabinol (HU-211) in the treatment of severe closed head injury: A randomized, placebo-controlled, phase II clinical trial. Crit Care Med30(3): 548–554.
54.
KokikoONMurashovAKHoaneMR (2006) Administration of raloxifene reduces sensorimotor and working memory deficits following traumatic brain injury. Behav Brain Res170: 233–240.
55.
LeeLLGaloELyethBGMuizelaarPBermanRF (2004) Neuroprotection in the rat lateral fluid percussion model of traumatic brain injury by SNX-185, an N-type voltage-gated calcium channel blocker. Exp Neurol190: 70–78.
LonghiLPeregoCOrtolanoFZanierERBianchiPStocchettiN. (2009) C1-inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice. Crit Care Med37(2): 659–665.
58.
LouinGMarchand-VerrecchiaCPalmierBPlotkineMJafarian-TehraniM (2006) Selective inhibition of inducible nitric oxide synthase reduces neurological deficit but not cerebral edema following traumatic brain injury. Neuropharmacology50: 182–190.
59.
LuDGoussevAChenJPannuPLiYMahmoodA. (2004a) Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury. J Neurotrauma21(1): 21–32.
60.
LuDMahmoodAGoussevASchallertTQuCZhangZG. (2004b) Atorvastatin reduction of intravascular thrombosis, increase in cerebral microvascular patency and integrity, and enhancement of spatial learning in rats subjected to traumatic brain injury. J Neurosurg101: 813–821.
61.
LuDMahmoodAQuCGoussevASchallertTChoppM (2005) Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J Neurotrauma22(9): 1011–1017.
62.
LuDMahmoodAZhangRLiYChoppM (2003) Unpregulation of neurogenesis and reduction in functional deficits following administration of DETA/NONOate, a nitric oxide donor, after traumatic brain injury in rats. J Neurosurg99: 351–361.
63.
LuDQuCGoussevAJiangHLuCSchallertT. (2007) Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury. J Neurotrauma24(7): 1132–1146.
64.
McIntoshTKVinkRSoaresHHayesRSimonR (1989) Effects of the N-Methyl-D-aspartate receptor blocker MK-801 on neurologic function after experimental brain injury. J Neurotrauma6(4): 247–259.
65.
MarklundNBareyreFMRoyoNCThompsonHJMirAKGradyMS. (2007) Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expression. J Neurosurg107: 844–853.
66.
MarklundNClausenFMcIntoshTKHilleredL (2001) Free radical scavenger posttreatment improves functional and morphological outcome after fluid percussion injury in the rat. J Neurotrauma8: 821–832.
67.
MbyeLHSinghINCarricoKMSaatmanKEHallED (2009) Comparative neuroprotective effects of cyclosporin A and NIM811, a nonimmunosuppressive cyclosporin A analog, following traumatic brain injury. J Cereb Blood Flow Metab29(1): 87–97.
68.
Morganti-KossmannMCSatgunaseelanLByeNKossmannT (2007) Modulation of immune response by head injury. Injury38: 1392–1400.
69.
NarayanRKMichelMEAnsellBBaethmannABiegonABrackenMB. (2002) Clinical trials in head injury. J Neurotrauma19(5): 503–557.
70.
O’ConnorCACernakIJohnsonFVinkR (2007) Effects of progesterone on neurologic and morphologic outcome following diffuse traumatic brain injury in rats. Exp Neurol205: 145–153.
71.
O’ConnorCACernakIVinkR (2003) Interaction between anesthesia, gender, and functional outcome task following diffuse traumatic brain injury in rats. J Neurotrauma20(6): 533–541.
72.
OkiyamaKSmithDHWhiteWFMcIntoshTK (1998) Effects of the NMDA antagonist CP-98,113 on regional cerebral edema and cardiovascular, cognitive, and neurobehavioral function following experimental brain injury in the rat. Brain Res792: 291–298.
73.
OkiyamaKSmithDHWhiteWRichterKMcIntoshTK (1997) Effects of the novel NMDA antagonists CP-98,113, CP-101,581 and CP-101,606 on cognitive function and regional cerebral edema following experimental brain injury in the rat. J Neurotrauma14(4): 211–222.
74.
OkuyamaSYamadaSOgawaS-IShimaKKamataKTomisawaK (2002) Effect of VA-045, a novel apovincaminic acid derivative, on closed head injury-induced neurological dysfunction in aged rats. Neurol Res19(3): 300–304.
75.
PappiusHM (1991) Brain injury: New insights into neurotransmitter and receptor mechanisms. Neurochem Res16(9): 941–949.
76.
PascualJMSoliveraJPrietoRBarriosLLopez-LarrubiaPCerdanS. (2007) Time course of early metabolic changes following diffuse traumatic brain injury in rats as detected by H NMR Spectroscopy. J Neurotrauma24(6): 944–959.
77.
PikeBRHammRJ (1997) Activating the posttraumatic cholinergic system for the treatment of cognitive impairment following traumatic brain injury. Pharmacol Biochem Behav57(4): 785–791.
78.
PillayNSKellawayLAKotwalGJ (2007) Vaccinia virus complement control protein significantly improves sensorimotor function recovery after severe head trauma. Brain Res1153: 158165.
RothsteinHRSuttonAJBorensteinM (2005) Publication Bias in Meta-analysis: Prevention, Assessment and Adjustments. Chichester: John Wiley & Sons Ltd.
81.
SchmankeTBarthTM (1997) Amphetamine and task-specific practice augment recovery of vibrissae-evoked forelimb placing after unilateral sensorimotor cortical injury in the rat. J Neurotrauma14(7): 459–468.
82.
ShapiraYArtruAAQassamNNavotNValdU (1995) Brain edema and neurologic status with rapid infusion of 0.9% saline or 5% dextrose after head trauma. J Neurosurg Anesthesiol7(1): 17–25.
83.
ShohamiENovikovMBassR (1995) Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Brain Res674: 55–62.
84.
ShohamiEYatsivIAlexandrovichAHaklaiRElad-SfadiaGGrossmanR. (2003) The ras inhibitor S-trans, trans-Farnesylthiosalicylic acid exerts long-lasting neuroprotection in a mouse closed head injury model. Journal of Cerebral Blood Flow & Metabolism23: 728–738.
85.
SilverJMMcAllisterTWYudofskySC (2005) Textbook of Traumatic Brain Injury. Washington: American Psychiatric Publishing Inc.
86.
SindhuFCarpenterLSeersK (1997) Development of a tool to rate the quality assessment of randomized controlled trials using a Delphi technique. J Adv Nurs25: 1262–1268.
87.
SinsonGPerriBRTrojanowskiJQFlammESMcIntoshTK (1997) Improvement of cognitive deficits and decreased cholinergic neuronal cell loss and apoptotic cell death following neurotrophin infusion after experimental traumatic brain injury. J Neurosurg86: 511–518.
88.
SinzEHKochanekPMDixonCEClarkRSBCarcilloJASchidingJK. (1999) Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. J Clin Invest104(5): 647–656.
89.
SmithJMLungaPStoryDHarrisNLe BelleJJamesMF. (2007) Inosine promotes recovery of skilled motor function in a model of focal brain injury. Brain130: 915–925.
90.
TanAAQuigleyASmithDCHoaneMR (2008) Strain differences in response to traumatic brain injury in Long-Evans compared to Sprague-Dawley rats. J Neurotrauma26: 539–548.
91.
TempleMDHammRJ (1996) Chronic, post-injury administration of D-cycloserine, an NMDA partial agonist, enhances cognitive performance following experimental brain injury. Brain Res741: 246–251.
92.
TilleyA (1996) An introduction to psychological research and statistics (3rd edn). Brisbane: Pineapple Press.
93.
TurnerRJVan den HeuvelCVinkR (2004) Amiloride increases neuronal damage after traumatic brain injury in rats. J Am Coll Nutr23(5): 534S–537S.
94.
ValesKBubenikova-ValesovaVKlementDStuchlikA (2006) Analysis of sensitivity to MK-801 treatment in a novel active allothetic place avoidance task and in the working memory version of the Morris Water Maze reveals differences between Long-Evans and Wistar rats. Neurosci Res55: 383–388.
95.
WagnerAKKlineAERenDWillardLAWengerMKZafonteRD. (2007) Gender associations with chronic methylphenidate treatment and behavioural performance following experimental traumatic brain injury. Behav Brain Res181: 200–209.
96.
WahlFRenouEMaryVStutzmannJ-M (1997) Riluzole reduces brain lesions and improves neurological function in rats after a traumatic brain injury. Brain Res756: 247–255.
97.
WebsterRA (2003) Neurotransmitters, Drugs and Brain Function. Chichester: John Wiley & Sons Ltd.
98.
YakaRBiegonAGrigoriadisNSimeonidouCGrigoriadisSAlexandrovichG. (2007) D-cycloserine improves functional recovery and reinstates long-term potentiation (LTP) in a mouse model of closed head injury. FASEB J21: 2033–2041.
99.
YatsivIGrigoriadisNSimeonidouCStahelPFSchmidtOIAlexandrovichAG. (2005) Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. FASEB J19(12): 1701–1703.
100.
YatsivIMorganti-KossmannMCPerezDDinarelloCANovickDRubinsteinM. (2002) Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J Cereb Blood Flow Metab22: 971–978.
101.
ZakzanisKK (2001) Statistics to tell the truth, the whole truth, and nothing but the truth: Formulae, illustrative numerical examples, and heuristic interpretation of effect size analyses for neuropsychological researchers. Arch Clin Neuropsychol16: 653–667.
ZamudioSFregosoTMirandaADe La CruzFFloresG (2005) Strain differences of dopamine receptor levels and dopamine related behaviors in rats. Brain Res Bull65: 339–347.
104.
ZarubinaIV (2003) Drug correction of behavioral reactions and metabolic disorders in rats with craniocerebral trauma. Bull Exp Biol Med1: 56–58.
105.
ZhuJHammRJReevesTMPovlishockJTPhillipsLL (2000) Postinjury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury. Exp Neurol166: 136–152.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
